Camtek Ltd. $CAMT Stock: Royce & Associates LP Grows Holdings

Royce & Associates LP grew its holdings in Camtek Ltd. (NASDAQ:CAMT) by 6.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 223,391 shares of the semiconductor company’s stock after purchasing an additional 12,680 shares during the quarter. Royce & Associates LP’s holdings in Camtek were worth $34,681,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of CAMT. Phoenix Financial Ltd. grew its position in shares of Camtek by 746.3% during the 3rd quarter. Phoenix Financial Ltd. now owns 2,013,214 shares of the semiconductor company’s stock worth $311,938,000 after buying an additional 1,775,319 shares during the period. Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Camtek by 15.6% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 3,060,896 shares of the semiconductor company’s stock worth $475,204,000 after buying an additional 412,500 shares during the last quarter. Ashton Thomas Private Wealth LLC raised its stake in shares of Camtek by 12.3% during the third quarter. Ashton Thomas Private Wealth LLC now owns 1,763 shares of the semiconductor company’s stock worth $274,000 after buying an additional 193 shares during the last quarter. Associated Banc Corp bought a new stake in shares of Camtek during the third quarter worth approximately $211,000. Finally, QRG Capital Management Inc. acquired a new position in Camtek in the second quarter valued at approximately $206,000. Institutional investors own 41.93% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on CAMT shares. B. Riley Financial reduced their price objective on shares of Camtek from $166.00 to $138.00 and set a “buy” rating on the stock in a research note on Monday, November 9th. Stifel Nicolaus set a $140.00 target price on shares of Camtek in a research report on Wednesday, November 4th. Needham & Company LLC cut their price target on Camtek from $170.00 to $130.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. Cantor Fitzgerald reissued a “neutral” rating and issued a $175.00 price target on shares of Camtek in a research note on Tuesday, September 22nd. Finally, Morgan Stanley lowered Camtek from an “equal weight” rating to an “underweight” rating and reduced their price target for the stock from $152.00 to $126.00 in a research report on Monday, November 2nd. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $164.00.

Camtek Stock Down 3.5%

Shares of NASDAQ CAMT traded down $3.69 during mid-day trading on Friday, reaching $101.73. 329,075 shares of the company’s stock were exchanged, compared to its average volume of 575,690. The firm has a market capitalization of $4.75 billion, a price-to-earnings ratio of 38.53, a PEG ratio of 1.56 and a beta of 1.69. The company has a current ratio of 5.85, a quick ratio of 5.18 and a debt-to-equity ratio of 0.65. The business has a fifty day simple moving average of $133.81 and a 200 day simple moving average of $155.04. Camtek Ltd. has a twelve month low of $89.13 and a twelve month high of $215.99.

Camtek (NASDAQ:CAMT) last released its quarterly earnings data on Wednesday, November 4th. The semiconductor company reported $0.99 earnings per share for the quarter, meeting the consensus estimate of $0.99. Camtek had a return on equity of 21.38% and a net margin of 24.56%. The business had revenue of $161.29 million for the quarter, compared to analysts’ expectations of $160.36 million. During the same quarter in the previous year, the business posted $0.82 EPS. Camtek’s revenue for the quarter was up 28.0% on a year-over-year basis. As a group, equities analysts expect that Camtek Ltd. will post 3.24 EPS for the current fiscal year.

Insider Transactions at Camtek

In other Camtek news, VP Orit Geva-Dvash sold 508 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $175.00, for a total transaction of $88,900.00. Following the sale, the vice president directly owned 5,205 shares in the company, valued at approximately $910,875. This trade represents a 8.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 79.40% of the company’s stock.

Key Camtek News

These are some of the CAMT news items that stood out recently:

• Neutral Sentiment: Recent coverage highlighted Camtek’s record third-quarter results and growth outlook, but framed 2027 as an execution test: the company will need to convert its outlook into sustained results. Camtek stock faces 2027 execution test after record Q3
• Negative Sentiment: Polen International Small Cap Fund reported exiting its Camtek position among its third-quarter portfolio moves. The sale may add to concerns about investor appetite, though it reflects one fund’s decision. Polen fund portfolio moves
• Negative Sentiment: Northland also lowered its Q4 2026 EPS estimate to $1.04 from $1.09 and its FY2026 forecast to $3.25 from $3.35, tempering the more optimistic 2027 revisions. Northland Securities estimate changes

About Camtek

Camtek Ltd. develops, manufactures and sells inspection and metrology equipment used in semiconductor manufacturing. Its systems help manufacturers detect defects and measure features on wafers and other components, supporting quality control as semiconductor devices become smaller and more complex. The company’s products serve applications including advanced packaging, memory, image sensors and other semiconductor processes. Camtek combines optical inspection hardware with software to analyze production data and identify issues during manufacturing.